PATENT CLAIM ANALYSIS

Application Number: 15757269
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-12
Patent Classification: ["424", "450000"]

Abstract:
The present disclosure is directed to methods of producing monosized protocells from monosized mesoporous silica nanoparticles (mMSNPs) and their use for targeted drug delivery formulations and systems and for biomedical applications. The present disclosure is also directed in part to a multilamellar or unilamellar protocell vaccine to deliver full length viral protein and/or plasmid encoded viral protein to antigen presenting cells (APCs) in order to induce an immunogenic response to a virus.

Claim (Index 3):
The population of protocells according to  claim 1 , wherein the nanoparticles are mesoporous.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 90.0
- Lexical Diversity: 1.36842
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14113371', '13143164', '12909572', '15320903', '14354706']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7542117756554708
- 35 USC 102 Novelty (BERT): 0.5613610996172719
- Combined Prediction Score: 0.7349267080516508
- Mean Citation Score: 348.0356040000001
- Max Citation Score: 464.6732
- Similarity Product: 330.8975382436037

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test